Dr. Melanie Ruyle Lerew, MD

Dr. Lerew practices at Oklahoma City VA Medical Center in Oklahoma City, Oklahoma, part of Veterans Health Administration.

Dr. Lerew's NPI, 1073824983, was assigned on June 24, 2010. Dr. Lerew graduated from UTMB Health in 2010. Dr. Lerew holds Texas license Q4448.

Dr. Lerew's primary practice is Oklahoma City VA Medical Center, at 921 NE 13th Street, Oklahoma City, OK 73104 in Oklahoma County. The practice phone is (405) 270-0501.

Dr. Lerew's primary practice is Oklahoma City VA Medical Center in Oklahoma City, Oklahoma, part of Veterans Health Administration. Dr. Lerew is also affiliated with United Regional. The medical group on file is The Centers for Advanced ENT Care, Texoma (formerly Texoma ENT & Allergy). Dmand AI also links Dr. Lerew to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lerew practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Lerew's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Lerew is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Lerew's licenses on file in 2 states: Texas and California.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Lerew treats.

CMS data shows 2,662 Medicare services from Dr. Lerew across 13 procedure codes in 2024, for 545 Medicare patients. Medicare paid $77,553 for them. Every service was in an office.

CMS counts 545 Medicare patients who saw Dr. Lerew in 2024. The largest group is 65 to 74, with 262 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lerew's median patient age at 47, with 61% women.

In 2024, Dr. Lerew wrote 566 Medicare Part D claims for 182 patients. 93% of them were for generic drugs. CMS names the drug for 448 of them, across 14 drugs with 11 or more claims each, at $108,711 in total drug cost. In 2023, CMS named 312 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Lerew for performance year 2024, reported individually. Dr. Lerew accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 123 general payments to Dr. Lerew from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $831.

Dmand AI lists 1 award for Dr. Lerew.

Dr. Lerew graduated from UTMB Health in 2010. Dr. Lerew is a member of NHS.

Dr. Lerew is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.